The mechanism of action of Botulinum toxin type a in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site

Journal of the Neurological Sciences

Volumn 152, Issue 2, 1997, Pages 132-135

  Giladi, Nir ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Afferent pathways; Botulinum toxin; CNS; Focal dystonia; Sensory trick

Indexed keywords

BOTULINUM TOXIN;

ARTICLE; DRUG EFFECT; DRUG EFFICACY; DYSTONIA; HUMAN; MOTONEURON; MUSCLE RELAXATION; MUSCLE WEAKNESS; PAIN; PRIORITY JOURNAL; SENSORY NERVE; SYNAPTOSOME;

AFFERENT PATHWAYS; ANIMALS; BOTULINUM TOXIN TYPE A; DYSTONIA; EFFERENT PATHWAYS; HUMANS; MODELS, NEUROLOGICAL; MOTOR NEURONS; NEUROMUSCULAR JUNCTION; PAIN;

EID: 0030710177     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(97)00151-2     Document Type: Article

References (42)

1. Acquardo, M.A., Borodic, G.E., 1994. Treatment of myofacial pain with botulinum toxin. Anesthesiology 80, 705-706.
2. American Academy of Neurology Assessment, 1990. The clinical usefulness of botulinum toxin-A in treating neurologic disorders. Report of the Therapeutics and Assessment Subcommittee of the American Academy of Neurology. Neurology 40, 1332-1336.
3. Blasi, J., Chapman, E.R., Link, E., Binz, T., Yamasaki, S., Camilli, P.D., Südhof, A., Niemann, H., Jahn, R., 1993. Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25. Nature 365, 160-163.
4. Brin, M.F., Fahn, S., Moskowitz, C.B., Blitzer, A., Friedman, A., Shale, H.M., Greene, P.E., List, T., Lange, D., Lovelace, R.E., McMahon, D., 1987. Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm. Mov. Disord. 2, 237-254.
5. Ceballos-Baumann, A.O., Sheehan, G., Passingham, R.E., Marsden, C.D., Brooks, D.J., 1995. Motor reorganization after botulinum toxin treatment for writer's cramp: a PET study. Mov. Disord. 10,(3) 389.
6. Cheshire, W.P., Abashian, S.W., Mann, J.D., 1994. Botulinum toxin in the treatment of myofacial pain syndrome. Pain 59, 65-69.
7. Chistyakov, A., Giladi, N., Hafner, H., Kidan, H., Soustiel, J.F., Honigman, S., Feinsod, M., 1994. The effect of botulinum toxin treatment for cranio-cervical torsion dystonia on brainstem auditory and trigeminal evoked potentials. Mov. Disord. 9,(Supplement 1) 138.
8. Consky, E.S., Lang, A.E., 1994. Clinical assessments of patients with cervical dystonia. In: Jankovic, J., Hallett, M. (Eds.), Therapy with Botulinum Toxin. Marcel Dekker, New York, pp. 211-237.
9. Cosgrove, A.P., Corry, I.S., Graham, H.K., 1994. Botulinum toxin in the management of the lower limb in cerebral palsy. Dev. Med. Child Neurol. 36,(5) 386-396.
10. Davies, J.R., Morgan, R.S., Wright, E.A., Payling Wright, G., 1953. The results of direct injections of botulinum toxin into the central nervous system of rabbits. J. Physiol. 120, 618-623.
11. Davis, D., Jabbari, B., 1993. Significant improvement of stiff person syndrome after paraspinal injection of botulinum toxin A. Mov. Disord. 8, 371-373.
12. Denislic, M., Pirtosek, Z., Vodusek, D.B., Zider, J., Meh, D., 1994. Botulinum toxin in the treatment of neurological disorders. In: Dusan, S., Zorec, R. (Eds.), Toxins and Exocytosis. Annals of the New York Academy of Sciences, vol. 710, pp. 76-87
13. Deuschl, G., Heiren, F., Kleedorfer, B., Wagner, M., Lucking, C.H., Poewe, W., 1992. Clinical and polymyographic investigation of spasmodic torticollis. J. Neurol. 239, 9-15.
14. Elston, J.S., Marsden, C.D., Grandas, F., Quinn, N.P., 1988. The significance of ophthalmological symptoms in idiopathic blepharospasm. Eye 2, 435-439.
15. Elston, J.S., 1994. Botulinum toxin for blepharospasm. In: Jankovic, J., Hallett, M. (Eds.), Therapy with Botulinum Toxin. Marcel Dekker, New York, pp. 191-197.
16. Fahn, S., 1988. Concept and classification of dystonia. In: Fahn, S., Marsden, C.D., Calne, D.B. (Eds.), Advances in Neurology, Dystonia 2, vol. 50. Raven Press, New York, pp. 1-8.
17. Filippi, G.M., Errico, P., Santarelli, R., Bagolini, B., Mann, E., 1993. Botulinum A toxin effects on rat jaw muscle spindles. Acta Otolaryngol. 113, 400-404.
18. Ghika, J., Reli, F., Growdon, J.H., 1993. Sensory symptoms in cranial dystonia: a potential role in the etiology? J. Neurol. Sci. 116, 142-147.
19. Giladi, N., Meer, J., Kidan, C., Greenberg, E., Gross, B., Honigman, S., 1994. Interventional neurology: botulinum toxin as a potent symptomatic treatment in neurology. Israel J. Med. Sci. 30,(11) 816-819.
20. Greene, P., Kang, U., Brin, M., Fahn, S., Flaster, E., 1990. Double-blind placebo controlled trial of botulinum toxin injections for the treatment of torticollis. Neurology 40, 1213-1218.
21. 125I-labeled neurotoxin from clostridium botulinum A: preparation, binding to synaptosomes and ascent to the spinal cord. Naunyn Schmiedeberg's Arch. Pharmacol. 281, 47-56.
22. Hallett, M., 1995. Is dystonia a sensory disorder?. Ann. Neurol. 38, 139-140.
23. Hamjian, J.A., Walker, F.O., 1994. Serial neurophysiological studies of intramuscular botulinum A toxin in human. Muscle Nerve 17, 1385-1392.
24. Jankovic, J., Brin, M.F., 1991. Therapeutic uses of botulinum toxin. N. Engl. J. Med. 234,(17) 1186-1194.
25. Jankovic, J., Orman, J., 1987. Botulinum toxin for cranial cervical dystonia: a double-blind placebo-controlled study. Neurology 37, 616-623.
26. Jankovic, J., 1994. Botulinum toxin in the treatment of dystonic tics. Mov. Disord. 9,(3) 347-349.
27. Kaji, R., Rothwell, J.C., Katayama, M., Ikeda, T., Kubori, T., Kohara, N., Mezaki, T., Shibasaki, H., Kimura, J., 1995. Tonic vibration reflex and muscle afferent block in writer's cramp. Ann. Neurol. 38, 155-162.
28. Legroux, R., Levaditi, J.-C., Jéramec, C., 1945. Influence des voies d'introduction de la toxine sur le botulisme expérimental du lapin. Ann. L'Institut Pasteur 71, 490-493.
29. Leis, A.A., Dimitrijevic, M.R., Delapasse, J.S., Sharkey, P.C., 1992. Modification of cervical dystonia by selective sensory stimulation. J. Neurol. Sci. 110, 79-89.
30. Mikhailov, V.V., Korolev, V.V., 1968. Mechanism of disturbances of electrical activity of spinal cord neurons in experimental botulism. Bull. Exp. Biol. Med. 66, 1201-1204.
31. Mikhailov, V.V., Mikhailov, V.Vas, 1975. Effect of pathogenic action of botulinus toxin of spinal motoneurons of various types. Bull. Exp. Biol. Med. 80, 1288-1290.
32. Moreno-López, B., Pastor, A.M., de la Cruz, R.R., Delgado-Garcia, J.M., 1997. Dose-dependent, central effects of botulinum neurotoxin type A: a pilot study in the alert behaving cat. Neurology 48, 456-464.
33. Nix, W.A., Butler, I.J., Roontga, S., Gutmann, L., Hopf, H.C., 1992. Persistent unilateral tibialis anterior muscle hypertrophy with complex repetitive discharges and myalgia. Report of two unique cases and responses to botulinum toxin. Neurology 42, 602-606.
34. Pestronk, A., Drachman, D.B., Griffin, J.W., 1976. Effect of botulinum toxin on trophic regulation of acetylcholine receptors. Nature 264, 787-789.
35. Priori, A., Berardelli, A., Mercuri, B., Manfredi, M., 1995. Physiological effects produced by botulinum toxin treatment of upper limb dystonia. Changes in reciprocal inhibition between forearm muscles. Brain 118, 801-807.
36. Rosales, R.L., Arimura, K., Takenaga, S., Osame, M., 1996. Extrafusal and intrafusal muscle effects in experimental botulinum toxin-A injection. Muscle Nerve 19, 488-496.
37. Scott, A., 1980. Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87, 1044-1049.
38. Shulman, L.M., Singer, C., Weiner, W.J., 1996. Improvement of both tardive dystonia and akathisia botulinum toxin injection. Neurology 46, 844-845.
39. Simpson, L.L., 1989. Peripheral actions of botulinum toxin. In: Simpson, L.L. (Ed.), Botulinum Neurotoxin and Tetanus Toxin. Academic Press, San Diego, pp. 153-178.
40. Tolosa, E., Marti, M.J., Kulisevsky, J., 1987. Botulinum toxin for cranial cervical dystonia: a double-blind placebo-controlled study. Neurology 38, 616-623.
41. 125I-Labelled botulinum A neurotoxin: pharmacokinetics in cats after intramuscular injection. Naunyn Schmiedeberg's Arch. Pharmacol. 292, 161-165.
42. Wiegand, H., Wellhöner, H.H., 1977. The action of botulinum A neurotoxin on the inhibition by antidromic stimulation of the lumbar monosynaptic reflex. Naunyn Schmiedeberg's Arch. Pharmacol. 298, 235-238.